Tirzepatides mechanism offers a broader and more potent therapeutic profile than GLP-1 receptor agonists alone, making it highly effective for managing type 2 diabetes and obesity, with emerging evidence suggesting potential benefits in cardiovascular risk reduction and nonalcoholic steatohepatitis (NASH)
Sip 250 to 500 mL of water or electrolyte solution with each meal to maintain gastric fluid balance
Freezing causes irreversible protein denaturation that renders tirzepatide ineffective or potentially harmful, and frozen medication should never be used
Future work should adopt longitudinal designs to assess therapeutic effects across temporal windows
Semaglutide is a GLP-1 receptor agonist that mimics incretin hormones to enhance insulin secretion, delay gastric emptying, and suppress appetite
Abstract The concept of treating diabetes with gut hormones was proposed in the early days of endocrinology (1902), but was not put into practice until the early 2000s